BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15983462)

  • 1. Local anesthetic interaction with human ether-a-go-go-related gene (HERG) channels: role of aromatic amino acids Y652 and F656.
    Siebrands CC; Schmitt N; Friederich P
    Anesthesiology; 2005 Jul; 103(1):102-12. PubMed ID: 15983462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HERG channels by the local anaesthetic articaine.
    Siebrands CC; Friederich P
    Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements of human ether-a-go-go-related gene channels for block by bupivacaine.
    Siebrands CC; Friederich P
    Anesthesiology; 2007 Mar; 106(3):523-31. PubMed ID: 17325511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
    Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local anaesthetic sensitivities of cloned HERG channels from human heart: comparison with HERG/MiRP1 and HERG/MiRP1 T8A.
    Friederich P; Solth A; Schillemeit S; Isbrandt D
    Br J Anaesth; 2004 Jan; 92(1):93-101. PubMed ID: 14665560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.
    Ridley JM; Milnes JT; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2004 Dec; 325(3):883-91. PubMed ID: 15541373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lidoflazine is a high affinity blocker of the HERG K(+)channel.
    Ridley JM; Dooley PC; Milnes JT; Witchel HJ; Hancox JC
    J Mol Cell Cardiol; 2004 May; 36(5):701-5. PubMed ID: 15135665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block.
    González T; Arias C; Caballero R; Moreno I; Delpón E; Tamargo J; Valenzuela C
    Br J Pharmacol; 2002 Dec; 137(8):1269-79. PubMed ID: 12466236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
    Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
    Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
    Sănchez-Chapula JA; Ferrer T; Navarro-Polanco RA; Sanguinetti MC
    Mol Pharmacol; 2003 May; 63(5):1051-8. PubMed ID: 12695533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.
    Park SJ; Kim KS; Kim EJ
    J Appl Toxicol; 2008 Mar; 28(2):104-11. PubMed ID: 17516459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
    Zhang P; Xing J; Luo A; Feng J; Liu Z; Gao C; Ma J
    J Pharm Pharmacol; 2013 Sep; 65(9):1321-8. PubMed ID: 23927470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Determinants for the High-Affinity Blockade of Human Ether-à-go-go-Related Gene K + Channel by Tolterodine.
    Wang N; Yang Y; Wen J; Fan XR; Li J; Xiong B; Zhang J; Zeng B; Shen JW; Chen GL
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):679-689. PubMed ID: 35881423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
    Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procaine, a state-dependent blocker, inhibits HERG channels by helix residue Y652 and F656 in the S6 transmembrane domain.
    Wang N; Ma JH; Zhang PH
    J Pharmacol Sci; 2013 Sep; 123(1):25-35. PubMed ID: 24005047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
    Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
    J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current.
    Siebrands CC; Binder S; Eckhoff U; Schmitt N; Friederich P
    Anesthesiology; 2006 Sep; 105(3):511-20. PubMed ID: 16931984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system.
    Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
    Anesthesiology; 2004 Aug; 101(2):390-8. PubMed ID: 15277922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
    Kiesecker C; Zitron E; Lück S; Bloehs R; Scholz EP; Kathöfer S; Thomas D; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):423-35. PubMed ID: 15599706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.